The association between SGLT2 inhibitors and new-onset acute coronary syndrome in the elderly: a population-based longitudinal cohort study

The association between SGLT2 inhibitors and new-onset acute coronary syndrome in the elderly: a population-based longitudinal cohort study

Abstract Background Several observational cohorts and meta-analytical studies on humans have shown that users of sodium-glucose cotransporter-2 inhibitors (SGLT2is) have a lower risk for new-onset acute coronary syndrome (ACS) than nonusers. However, some studies, including randomized clinical trial...

Full description

Bibliographic Details
Main Authors: Tsung-Kun Lin, Mei-Chun Lee, Yu-Han Cheng, Timothy Ma, Mei-Chun Chen, Tsung-Yuan Yang, Gwo-Ping Jong
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Sodium–glucose co-transporter inhibitors
Diabetes mellitus
Acute coronary syndrome
Online Access:https://doi.org/10.1186/s13098-023-01143-5

Internet

https://doi.org/10.1186/s13098-023-01143-5

Similar Items